Buflomedil falls off Loftyl perch and Celecoxib COX-2 as CHMP concludes reviews
20 May 2011
Mike Ward
Please Login to read the full article.
20 May 2011
Mike Ward
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA makes it official: AstraZeneca's Iressa, Sanofi's Oforta NDAs withdrawn
- Benefit-risk balance of orlistat is positive, says EMA
- Pharmanova to commercialise MediGene's Veregen in South-eastern Europe
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
